Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study
Crossref DOI link: https://doi.org/10.1007/s12325-022-02179-1
Published Online: 2022-05-25
Published Print: 2022-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moretti, Antimo
Liguori, Sara
Paoletta, Marco
Gimigliano, Francesca
Iolascon, Giovanni
Text and Data Mining valid from 2022-05-25
Version of Record valid from 2022-05-25
Article History
Received: 7 March 2022
Accepted: 4 May 2022
First Online: 25 May 2022